{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:00:33Z","timestamp":1765609233728},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2357,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Gastrointestinal haemorrhage is a common complication of duodenal ulcers. Patients who bleed are at substantial risk of recurrent bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To determine whether appropriate therapeutic steps were taken to reduce the risk of recurrent haemorrhage in patients with a bleeding duodenal ulcer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The management of patients surviving a duodenal ulcer bleed in the University Hospital, Nottingham, was assessed by case\u2010note review before (1993) and after (1995\u20131996) institution of clinical guidelines. The following measures aimed at reducing the risk of recurrent haemorrhage were considered appropriate: stopping non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) when these were implicated in bleeding; successful eradication of <jats:italic>Helicobacter pylori<\/jats:italic> if present; and long\u2010term maintenance acid\u2010suppression therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>In 1993, appropriate steps were taken to reduce the risk of recurrent haemorrhage in only 48% of cases. Following the institution of guidelines, management improved significantly in 1995\u20131996 (appropriate in 83% of cases, <jats:italic>P<\/jats:italic>&lt;0.001), was associated with increased referral to gastroenterologists (<jats:italic>P<\/jats:italic>&lt;0.001), improved patient compliance with follow\u2010up (<jats:italic>P<\/jats:italic>&lt;0.05), and more rigorous attempts to identify (<jats:italic>P<\/jats:italic>&lt;0.001) and ensure clearance (<jats:italic>P<\/jats:italic>&lt;0.001) of <jats:italic>H.\u2423pylori<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>In this study, inadequate long\u2010term management of patients with a bleeding duodenal ulcer was common. This was due to a failure to adopt strategies aimed at reducing the risk of ulcer relapse and rebleeding. The quality of care improved significantly following the institution of guidelines and encouragement to refer to gastroenterologists.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1997.00178.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T11:46:44Z","timestamp":1068810404000},"page":"505-510","source":"Crossref","is-referenced-by-count":4,"title":["The long\u2010term management of patients with bleeding duodenal ulcers"],"prefix":"10.1111","volume":"11","author":[{"given":"M. E.","family":"McAlindon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S. W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","unstructured":"JohnstonSJ JonesPF KyleJ NeedhamCDEpidemiology and course of gastrointestinal haemorrhage in North\u2010East Scotland. Br Med J1973;11: 655.","DOI":"10.1136\/bmj.3.5882.655"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","unstructured":"JensenDM ChengS KovacsTOG et al. A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. N Engl J Med1994;11:382\u20136.","DOI":"10.1056\/NEJM199402103300602"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","unstructured":"DammanHG&WalterTAEfficacy of continuous therapy for peptic ulcer in controlled clinical trials. Aliment Pharmacol Ther1993;11(Suppl. 2):17\u201325.","DOI":"10.1111\/j.1365-2036.1993.tb00595.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","unstructured":"PenstonJG&WormsleyKG. Review article: maintenance treatment with H2\u2010receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther1992;11:3\u201329.","DOI":"10.1111\/j.1365-2036.1992.tb00541.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","unstructured":"RockallTA LoganRFA DevlinHB NorthfieldTC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Br Med J1995;11:222\u20136.","DOI":"10.1136\/bmj.311.6999.222"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","unstructured":"DobrillaG ZancanellaL AmplatzSThe need for long\u2010term treatment of peptic ulcer. Aliment Pharmacol Ther1993;11(Suppl. 2):3\u201315.","DOI":"10.1111\/j.1365-2036.1993.tb00594.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","unstructured":"FischerL MadsenMR ThomsenH H\u00f8stV WaraPPeptic ulcer haemorrhage: factors predisposing to recurrence. Scand J Gastroenterol1994;11:414\u20138.","DOI":"10.3109\/00365529409096831"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","unstructured":"LaineL&PetersonWL. Review article: bleeding peptic ulcer. N Engl J Med1994;11:717\u201325.","DOI":"10.1056\/NEJM199409153311107"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","unstructured":"PenstonJG&WormsleyKG. Nine years of maintenance treatment with ranitidine for with duodenal ulcer disease. Aliment Pharmacol Ther1992;11:629\u201345.","DOI":"10.1111\/j.1365-2036.1992.tb00577.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","unstructured":"JensenDM. Ranitidine and recurrent haemorrhage from duodenal ulcer. N Engl J Med1994;11: 53(Letter).","DOI":"10.1056\/NEJM199407073310115"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","unstructured":"HawkeyCJ. Review article: aspirin and gastrointestinal bleeding. Aliment Pharmacol Ther1994;11:141\u20136.","DOI":"10.1111\/j.1365-2036.1994.tb00271.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","unstructured":"GrahamDY HeppsKS RamirezFC LewGM SaeedZA. Treatment ofHelicobacter pylorireduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol1993;11:939\u201342.","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","unstructured":"LabenzJ&B\u00f6rschGRole ofHelicobacter pylorieradication in the prevention of peptic ulcer bleeding relapse. Digestion1994;11:19\u201323.","DOI":"10.1159\/000201117"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","unstructured":"RokkasT KaramerisA MavrogeorgisA RallisE GiannikosN. Eradication ofHelicobacter pylorireduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc1995;11:1\u20134.","DOI":"10.1016\/S0016-5107(95)70266-0"},{"key":"e_1_2_1_16_2","unstructured":"JaspersenD KoernerT SchorrW et al.Helicobacter pylorieradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest Endosc1995;11:5\u20137."},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","unstructured":"TytgatGNJ NoachLA RauwsEAJ.Helicobacter pyloriinfection and duodenal ulcer disease. Gastroenterol Clin North Am1993;11:127\u201339.","DOI":"10.1016\/S0889-8553(21)00268-5"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","unstructured":"CutlerAF HavstadS MaCK et al. Accuracy of invasive and noninvasive tests to diagnoseHelicobacter pyloriinfection. Gastroenterology1995;11:136\u201341.","DOI":"10.1016\/0016-5085(95)90278-3"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","unstructured":"HawkeyCJ. Healing and prevention of NSAID\u2010induced peptic ulcers. Scand J Gastroenterol1994;11(Suppl 201):42\u20134.","DOI":"10.3109\/00365529409105361"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","unstructured":"GoddardAF&SpillerRC.Helicobacter pylorieradication in clinical practice: one\u2010week low\u2010dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther1996;11:1009\u201313.","DOI":"10.1046\/j.1365-2036.1996.95267000.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00178.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00178.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:54:45Z","timestamp":1698414885000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00178.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00178.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00178.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}